Put your knowledge to the test and see how you stack up relative to your fellow clinicians! Challenge yourself with this self-paced interactive assessment designed to sharpen your knowledge and competency in risk stratification and triaging of patients for either conservative or invasive strategies, selecting appropriate antiplatelet therapy, and managing the variability of response to antiplatelet therapy.
Upon completion of this activity participants will be able to:
Deepak L. Bhatt, MD, MPH (Chair) Type of financial relationships:
Advisory Board: Regado Biosciences
Research Grants: Amarin, AstraZeneca Pharmaceuticals LP, Bristol-Myers Squibb Company, Eisai, Ethicon, Medtronic, Roche, Sanofi Aventis, and The Medicines Company
Discussion of Off-Label, Investigational, or Experimental Drug Use: Antiplatelet therapy – aspirin, clopidogrel, prasugrel, ticagrelor, cangrelor
ACHL staff members and others involved with the planning, development, and review of the content for this activity have no relevant affiliations or financial relationships to disclose.
Sponsored by the Academy for Continued Healthcare Learning